TECHCYTE FUSION Trademark

Trademark Overview


On Friday, June 14, 2024, a trademark application was filed for TECHCYTE FUSION with the United States Patent and Trademark Office. The USPTO has given the TECHCYTE FUSION trademark a serial number of 98601487. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, September 9, 2024. This trademark is owned by Techcyte, Inc.. The TECHCYTE FUSION trademark is filed in the Education & Entertainment Services category with the following description:

Educational services, namely, providing training of technicians, medical students, and pathologists for certification in the field of digital pathology
techcyte fusion

General Information


Serial Number98601487
Word MarkTECHCYTE FUSION
Filing DateFriday, June 14, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, September 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesEducational services, namely, providing training of technicians, medical students, and pathologists for certification in the field of digital pathology

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateFriday, June 14, 2024
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTechcyte, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOrem, UT 84058

Trademark Events


Event DateEvent Description
Friday, June 14, 2024NEW APPLICATION ENTERED
Friday, September 6, 2024ASSIGNED TO EXAMINER
Monday, September 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 9, 2024NON-FINAL ACTION WRITTEN
Monday, September 9, 2024NON-FINAL ACTION E-MAILED
Tuesday, September 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED